Author:
Kumari Kanika,Malik Renuka,Hada Ayushi,Goel Himanshi
Publisher
Jaypee Brothers Medical Publishing
Reference17 articles.
1. 1. Stewart EA, Cookson CL, Gandolfo RA, et al. Epidemiology of uterine fibroids: A systematic review. Int J Obstet Gynaecol 2017;124(10): 1501–1512. DOI: 10.1111/1471-0528.14640.
2. 2. Rezk A, Kahn J, Singh M. Fertility Sparing Management in Uterine Fibroids. [Updated 2023 Apr 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK574504/.
3. 3. Wagenfeld A, Saunders PT, Whitaker L, et al. Selective progesterone receptor modulators (SPRMs): Progesterone receptor action, mode of action on the endometrium and treatment options in gynaecological therapies. Expert Opin Ther Targets 2016;20(9):1045–1054. DOI: 10.1080/14728222.2016.1180368.
4. 4. Kulshreshtha V, Kriplani A, Agarwal N, et al. Low dose mifepristone in medical management of uterine leiomyoma – An experience from a tertiary care hospital from North India. Indian J Med Res 2013;137(6):1154–1162. PMID: 23852296.
5. 5. Lamba S, Singh A, Roy P, et al. Mifepristone in fibroids: An alternative! J South Asian Feder Obst Gynae 2018;10(1):29–32. DOI: 10.5005/jp-journals-10006-1553.